{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:27:45Z","timestamp":1793600865789,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jad.2026.121716","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:02:46Z","timestamp":1774882966000},"page":"121716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["From clinic to home: At-home neuromodulation for depression and the clinical significance of recent FDA approvals"],"prefix":"10.1016","volume":"406","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1362-3352","authenticated-orcid":false,"given":"Idris","family":"Altinisik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alikhan","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2026.121716_bb0005","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m11725","article-title":"Direct and indirect cost burden and change of employment status in treatment-resistant depression: a matched-cohort study using a US commercial claims database","volume":"79","author":"Amos","year":"2018","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2026.121716_bb0010","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jad.2018.04.016","article-title":"Treatment-resistant depression and suicidality","volume":"235","author":"Bergfeld","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121716_bb0015","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/jamapsychiatry.2023.4948","article-title":"Home-use transcranial direct current stimulation for the treatment of a major depressive episode: a randomized clinical trial","volume":"81","author":"Borrione","year":"2024","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2026.121716_bb0020","series-title":"BrainsWay receives FDA clearance of deep TMS as adjunct therapy for major depressive disorder (MDD) in adolescents aged 15 to 21","author":"BrainsWay","year":"2025"},{"key":"10.1016\/j.jad.2026.121716_bb0025","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.brs.2025.08.022","article-title":"A novel home-based, combined occipital and trigeminal afferent stimulation therapy for major depressive disorder: efficacy and safety results from a double-blind multicenter randomized sham-controlled study","volume":"18","author":"Carpenter","year":"2025","journal-title":"Brain Stimul."},{"key":"10.1016\/j.jad.2026.121716_bb0030","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1176\/appi.ajp.2021.20101429","article-title":"Stanford neuromodulation therapy (SNT): a double-blind randomized controlled trial","volume":"179","author":"Cole","year":"2022","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.121716_bb0035","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyaf080","article-title":"Durability of the benefit of vagus nerve stimulation in markedly treatment-resistant major depression: a RECOVER trial report","volume":"29","author":"Conway","year":"2026","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2026.121716_bb0040","doi-asserted-by":"crossref","first-page":"963","DOI":"10.4088\/JCP.v63n1102","article-title":"The impact of treatment-resistant depression on health care utilization and costs","volume":"63","author":"Crown","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2026.121716_bb0045","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1001\/jamapsychiatry.2023.4599","article-title":"Clinical outcomes of magnetic seizure therapy vs electroconvulsive therapy for major depressive episode: a randomized clinical trial","volume":"81","author":"Deng","year":"2024","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2026.121716_bb0050","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2026.121716_bb0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1192\/bjp.2021.116","article-title":"Shock tactics, ethics and fear: an academic and personal perspective on the case against electroconvulsive therapy","volume":"220","author":"Gergel","year":"2022","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.121716_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115611","article-title":"Long-term cognitive effects of electroconvulsive therapy in major depressive disorder: a systematic review and meta-analysis","volume":"331","author":"Guo","year":"2024","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2026.121716_bb0065","article-title":"Efficacy and safety of repetitive transcranial magnetic stimulation for major depressive disorder: a systematic review and meta-analysis","volume":"104","author":"He","year":"2025","journal-title":"Medicine"},{"key":"10.1016\/j.jad.2026.121716_bb0070","article-title":"Ultrabrief pulse electroconvulsive therapy for depression: a systematic review and meta-analysis","author":"Jelovac","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2026.121716_bb0075","first-page":"168","article-title":"Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization\u2019s world mental health survey initiative","volume":"6","author":"Kessler","year":"2007","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jad.2026.121716_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci15111244","article-title":"Deep brain stimulation in treatment-resistant psychiatric disorders: efficacy, safety, and future directions","volume":"15","author":"Khosravi","year":"2025","journal-title":"Brain Sci."},{"issue":"9","key":"10.1016\/j.jad.2026.121716_bb0085","article-title":"Neuromodulation approaches to depressive disorders","volume":"40","author":"Kim","year":"2023","journal-title":"Psychiatr. Times"},{"key":"10.1016\/j.jad.2026.121716_bb0090","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00406-023-01620-y","article-title":"TDCS at home for depressive disorders: an updated systematic review and lessons learned from a prematurely terminated randomized controlled pilot study","volume":"273","author":"Kumpf","year":"2023","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2026.121716_bb0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamapsychiatry.2022.3860","article-title":"Association of treatment-resistant depression with patient outcomes and health care resource utilization in a population-wide study","volume":"80","author":"Lundberg","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2026.121716_bb0100","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/wps.21120","article-title":"Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions","volume":"22","author":"McIntyre","year":"2023","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jad.2026.121716_bb0105","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/0706743716660033","article-title":"Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 4. Neurostimulation treatments","volume":"61","author":"Milev","year":"2016","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.121716_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2019.109836","article-title":"Efficacy and acceptability of transcranial direct current stimulation (tDCS) for major depressive disorder: an individual patient data meta-analysis","volume":"99","author":"Moffa","year":"2020","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2026.121716_bb0115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.12703\/r\/12-13","article-title":"Recent advances in electroconvulsive therapy in clinical practice and research","volume":"12","author":"Mukhtar","year":"2023","journal-title":"Faculty Rev."},{"key":"10.1016\/j.jad.2026.121716_bb0120","article-title":"Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis","volume":"364","author":"Mutz","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2026.121716_bb0125","series-title":"Neurolief receives FDA PMA approval for first at-home brain neuromodulation therapy for adults whose depression was not adequately improved by antidepressants","author":"Neurolief Inc","year":"2026"},{"key":"10.1016\/j.jad.2026.121716_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2023.110752","article-title":"Time-course of the tDCS antidepressant effect: an individual participant data meta-analysis","volume":"125","author":"Nikolin","year":"2023","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2026.121716_bb0135","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.15881","article-title":"Repetitive transcranial magnetic stimulation as maintenance treatment of depression: the MAINT-R randomized clinical trial","volume":"8","author":"Noda","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jad.2026.121716_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2025.120483","article-title":"Long-term efficacy and safety of vagus nerve stimulation in treatment-resistant depression: a systematic review","volume":"394","author":"Rosson","year":"2026","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121716_bb0145","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.121716_bb0150","series-title":"Premarket approval P230024: flow FL-100 cranial electrotherapy stimulator","author":"US Food and Drug Administration","year":"2025"},{"key":"10.1016\/j.jad.2026.121716_bb0155","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41591-024-03305-y","article-title":"Home-based transcranial direct current stimulation treatment for major depressive disorder: a fully remote phase 2 randomized sham-controlled trial","volume":"31","author":"Woodham","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.jad.2026.121716_bb0160","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20m13699","article-title":"The prevalence and national burden of treatment-resistant depression and major depressive disorder in the United States","volume":"82","author":"Zhdanava","year":"2021","journal-title":"J. Clin. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726005677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726005677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:41:47Z","timestamp":1793598107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032726005677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":32,"alternative-id":["S0165032726005677"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.121716","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From clinic to home: At-home neuromodulation for depression and the clinical significance of recent FDA approvals","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.121716","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121716"}}